CircRNA-SORE is upregulated in sorafenib-resistant HCC cells, and circRNA-SORE binds the master oncogenic protein YBX1 (Y box binding protein 1) to prevents its interaction with the E3 ubiquitin ligase to block YBX1 degradation. Here, YBX1 is linked to hepatocellular carcinoma.